- This event has passed.
Marijuana and Teens
June 14 @ 10:00 am - 12:00 pm
Marijuana and Teens: What Clinicians & Educators Need to Know
Mary A. Fristad, PhD, ABPP & Natalie Powell, MS Ed, LPCC-S, LICDC-CS
DATE: Monday, June 14, 2021
TIME: 10:00 AM–12:00 PM EDT
VENUE: LIVE WEBINAR
FEE: $90 ($65 for students and for registrants in groups of 3 or more)
Includes technical support, handouts, and Continuing Education credits
Registration is limited and on a first-come-first-served basis
This 2-hour workshop will provide information on current trends in legalization of medical and recreational marijuana in the United States, explore the biology of cannabis use, particularly in adolescent brains, present statistics on adolescent marijuana use, discuss risks and benefits of use, review prevention strategies, and describe clinical strategies for addressing use in this age group.
Some of the questions to be addressed include:
- Are the rates of marijuana usage higher in those states that have legalized it (e.g., Colorado)?
- What is CBD and THC and how are they different?
- Why has marijuana become so much more potent in the last decade? What are the implications?
- Is marijuana processed differently in adolescent than in adults? Why?
- True or False: Marijuana use is implicated in increased difficulties in Executive Dysfunction, anxiety, depressive symptoms, impulsivity uniquely in adolescents and emerging adults which can lead to persistent and enduring changes in brain function.
- What percentage of marijuana experimenters end up addicted?
- Are there any benefits to CBD or THC?
- Is marijuana a risk factor to develop schizophrenia, depression, or memory deficits?
- What are the differences between smoking or orally ingesting (edibles) marijuana?
- On a community-wide level, what can be done to minimize marijuana usage among adolescents?
- How can one apply motivational interviewing to help those struggling with marijuana usage?
- Can cognitive-behavioral therapy help?
- What is the best way to provide psychoeducation to adolescents and families?
- What is a functional analysis and how can it be effective?
- How can we use problem solving skills, relaxation techniques, and substitute activities?
- How important is family therapy and how is it carried out?
- Under what circumstances would a specialized program be necessary?
- How can one motivate parents to be a role-model if they themselves are engaging in this behavior?
- Should clinicians directly ask children/teens if they are engaged in marijuana usage?
- What additional resources are recommended for further information on this topic?
At the conclusion of this program, participants will be better able to:
- Describe change in potency of marijuana.
- Identify the two most common cannabinoids.
- State 3 clinical strategies for addressing use.
Meet the Instructors:
Mary A. Fristad, PhD, ABPP, is Director of Research Development and Academic Affairs in Behavioral Health at Nationwide Children’s Hospital and an Emerita Professor of Psychiatry and Behavioral Health, Psychology, and Nutrition at the Ohio State University. She has served on the inaugural executive boards and been president of both the Society of Clinical Child and Adolescent Psychology and the American Board of Clinical Child and Adolescent Psychology.
Dr. Fristad has been an active NIH-funded researcher for nearly 40 years, including serving as PI, or Co-PI, on multiple clinical trials. Her research focuses on the assessment and treatment of mood disorders in youth including youth with depression and bipolar disorder as well as substance abuse disorders. She has authored over 200 publications, including a treatment manual, book for parents, and workbooks for therapists, parents, children, and adolescents with mood disorders. In addition, Dr. Fristad conducts trainings internationally. She also serves on the Executive Committee of the Administrative Core and as a co-leader for the Training in Prevention of Suicide (TiPS) program.
Natalie Powell, MS Ed, LPCC-S, LICDC-CS is the clinical lead supervisor for substance abuse treatment programming in Behavioral Health at Nationwide Children’s Hospital. She has been providing treatment in the addictions field since 2006.
Natalie is a Licensed Professional Clinical Counselor with Supervisor distinction (LPCC-S) as a well as a Licensed Independent Chemical Dependency Counselor – Clinicial Supervisor (LICDC-CS). Her specialties include working with adolescents with substance abuse concerns, suicidal and self-injurious behaviors, and/or involvement with the criminal justice system.
Continuing Education Credit (2) will be granted through Commonwealth Educational Seminars for the following professions: Psychologists, Social workers, Mental Health Counselors, and LMFTs. It is the participant’s responsibility to check with their individual state boards to verify CE requirements for their state.
Commonwealth Educational Seminars is approved by the American Psychological Association to sponsor continuing education for psychologists. Commonwealth Educational Seminars maintains responsibility for these programs and their content.
Commonwealth Educational Seminars (CES) is entitled to award continuing education credit for Social Workers. Please visit CES CE CREDIT to see all states that are covered for Social Workers. CES maintains responsibility for this program and its content.
Commonwealth Educational Seminars is recognized by the New York State Education Department’s State Board for Social Work as an approved provider of continuing education for licensed social workers. #SW-0444.
Recommended reading to prepare for the workshop:
Carver, A.E, Jorgensen, J., Barberio, M.W., Lomuscio, C.E. & Brumbaugh, D. (2020). A pediatric hospital policy for medical marijuana use. Pediatrics, e20194079.
Chandra, S. Radwan, M.M., Majumdar, C.G., Church, J.C., Freeman, T.P. & El Sohly, M.A. (2019). New trends in cannabis potency in USA and Europe during the last decade (2008-2017). Eur Arch Psychiatry Clin Neurosci, 269(1): 5-15.
Fontanella, C.A., Steelesmith, D.L., Brock, G., Bridge, J.A., Campo, J.V., & Fristad, M.A. (in press). Association between cannabis use, self-harm, and mortality risk among youth with mood disorders. JAMA Pediatrics. doi:10.1001/jamapediatrics.2020.5494
Gobbi, G., et al. (2019). Association of cannabis use in adolescence and risk of depression, anxiety, and suicidality in young adulthood: A systematic review and metal-analysis. JAMA Psychiatry, 76(4): 426-434.
Goldston, D. B., Curry, J.F., Wells, K.C., Kaminer, Y., Daniel, S.S., Esposito-Smythers, C., Doyle, O., Sapyta, J., Tunno, A.M., Heilbron, N. & Roley-Roberts, M. (2021). Feasibility of an integrated treatment approach for youth with depression, suicide attempts, and substance use problems. Evidence-Based Practice in Child and Adolescent Mental Health. DOI: 10.1080/23794925.2021.1888664
Murray, R. & Hall, W. (2020). Will legalization and commercialization of cannabis use increase the incidence and prevalence of psychosis? JAMA Psychiatry, doi:10.1001/jamapsychiatry.2020.0339
Volkow, N.D., Han, B., Einstein, E.B., et al. (in press). Prevalence of substance use disorders by time since first substance use among young people in the US. JAMA Pediatrics, doi:10.1001/jamapediatrics.2020.6981
Target audience: Mental Health & Associated Professionals,
June 12, 2021 or until all training spaces are filled, whichever comes first.
Notification of Acceptance
Applicants will be notified, via email, of acceptance when registration is complete and payment is received.
Tuition/registration payments are refundable until May 14th, 2021. Cancellations after this date are non-refundable but registrant will be entitled to a credit towards a future training. . In this situation, we will attempt to find someone to take your slot (based on our waiting list).
Webinar workshops accommodate are accessible. For further information, please contact: firstname.lastname@example.org or 917-862-2427
Nachas Consulting seeks to ensure equitable treatment of every person and to make every attempt to resolve grievances in a fair manner. Please submit a written grievance to email@example.com or 917-862-2427. Grievances will receive, to the best of our ability, corrective action in order to prevent further problems.
Accommodations for the disabled.
Webinar workshops accommodate the disabled. For further information, please contact: firstname.lastname@example.org or 917-862-2427
PLEASE NOTE: UPON SUBMITTING THIS FORM YOU MAY EXPERIENCE A DELAY IN FORWARDIG TO THE PAYPAL PAGE. PLEASE ALSO NOTE THAT IF YOU DO NOT HAVE A PAYPAL ACCOUNT YOU MAY NEED TO SCROLL DOWN A BIT TO SEE THE PAY WITH CREDIT CARD OPTION.